Stock Earnings

Question 1

What are Livzon Pharmaceutical Group Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Livzon Pharmaceutical Group Inc has a total asset of $24,455, Net profit of $2,061

Question 2

What are the key financial ratios for LVZPF?

Accepted Answer

Livzon Pharmaceutical Group Inc's Current ratio is 2.3, has a Net margin is 17.44, sales per share of $12.83.

Question 3

How is Livzon Pharmaceutical Group Inc's revenue broken down by segment or geography?

Accepted Answer

Livzon Pharmaceutical Group Inc largest revenue segment is Chemical Drug Preparations, at a revenue of 6,119,280,577 in the most earnings release.For geography, China is the primary market for Livzon Pharmaceutical Group Inc, at a revenue of 9,976,999,763.

Question 4

Is Livzon Pharmaceutical Group Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Livzon Pharmaceutical Group Inc has a net profit of $2,061

Question 5

Does Livzon Pharmaceutical Group Inc have any liabilities?

Accepted Answer

yes, Livzon Pharmaceutical Group Inc has liability of 10,593

Question 6

How many outstanding shares for Livzon Pharmaceutical Group Inc?

Accepted Answer

Livzon Pharmaceutical Group Inc has a total outstanding shares of 903.64

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	11,846	11,812	12,430	12,629	12,063	10,520
Revenue Growth (YoY)	0%	-5%	-2%	5%	15%	12%
Cost of Revenue	4,191	4,157	4,774	4,577	4,309	3,744
Gross Profit	7,654	7,654	7,655	8,051	7,754	6,777
Selling, General & Admin	4,007	3,932	4,322	4,606	4,601	3,791
Research & Development	982	931	973	1,208	1,066	827
Operating Expenses	4,982	4,912	5,551	5,945	5,634	4,531
Other Non Operating Income (Expenses)	-40	-33	-32	-6	-15	-6
Pretax Income	2,999	2,806	2,382	2,330	2,245	2,489
Income Tax Expense	510	501	485	374	293	358
Net Income	2,142	2,061	1,953	1,909	1,775	1,715
Net Income Growth	6%	6%	2%	8%	4%	32%
Shares Outstanding (Diluted)	893.11	920.35	930.3	935.98	934.57	939
Shares Change (YoY)	-4%	-1%	-1%	0%	0%	0%
EPS (Diluted)	2.38	2.23	2.1	2.04	1.9	1.83
EPS Growth	9%	7%	3%	7%	4%	32%
Free Cash Flow	2,536	2,408	2,428	1,832	593	1,513
Free Cash Flow Per Share	2.83	2.61	2.6	1.95	0.63	1.61
Gross Margin	64.61%	64.79%	61.58%	63.75%	64.27%	64.42%
Operating Margin	22.54%	23.21%	16.91%	16.67%	17.56%	21.34%
Profit Margin	18.08%	17.44%	15.71%	15.11%	14.71%	16.3%
Free Cash Flow Margin	21.4%	20.38%	19.53%	14.5%	4.91%	14.38%
EBITDA	--	2,928	2,559	2,413	2,289	2,377
EBITDA Margin	--	24.78%	20.58%	19.1%	18.97%	22.59%
D&A For EBITDA	--	186	456	307	170	131
EBIT	2,671	2,742	2,103	2,106	2,119	2,246
EBIT Margin	22.54%	23.21%	16.91%	16.67%	17.56%	21.34%
Effective Tax Rate	17%	17.85%	20.36%	16.05%	13.05%	14.38%

Livzon Pharmaceutical Group Inc (LVZPF) Price

LVZPF Stock Price Chart

LVZPF Income

Follow-Up Questions